Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)
Terminated
- Conditions
- Indolent Non Hodgkin's Lymphoma (iNHL)Chronic Lymphocytic Leukaemia (CLL)
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2016-06-21
- Lead Sponsor
- Astellas Pharma International B.V.
- Target Recruit Count
- 25
- Registration Number
- NCT02273856
- Locations
- 🇯🇴
Site JO96201 King Abdullah University Hospital, Irbid, Jordan
🇰🇼Site KW96501 Kuwait Cancer Control Center, Shuwaikh, Kuwait
🇱🇧Site Hammoud Hospital University Medical Center, Beirut, Lebanon
News
No news found